Cargando…

Screening and Identification of Survival-Associated Splicing Factors in Lung Squamous Cell Carcinoma

Lung squamous cell carcinoma (LUSC) is a disease with high morbidity and mortality. Many studies have shown that aberrant alternative splicing (AS) can lead to tumorigenesis, and splicing factors (SFs) serve as an important function during AS. In this research, we propose an analysis method based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Min, Zhu, Rui, Zhang, Fangzhou, Zhu, Liucun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811261/ https://www.ncbi.nlm.nih.gov/pubmed/35126467 http://dx.doi.org/10.3389/fgene.2021.803606

Ejemplares similares

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

DASES: a database of alternative splicing for esophageal squamous cell carcinoma
por: Chen, Yilong, et al.
Publicado: (2023)

Identifying Discriminative Biological Function Features and Rules for Cancer-Related Long Non-coding RNAs
por: Zhu, Liucun, et al.
Publicado: (2020)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022)

Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma
por: Zhang, Rusi, et al.
Publicado: (2022)

Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and Adenocarcinoma
por: Polewko-Klim, Aneta, et al.
Publicado: (2022)

A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Huili, et al.
Publicado: (2022)

Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma
por: Wu, Shuo, et al.
Publicado: (2019)

Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma
por: Wu, Xiaohong, et al.
Publicado: (2020)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
por: Wu, Sijia, et al.
Publicado: (2021)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Survival association of XRCC1 for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis
por: Yang, Fan, et al.
Publicado: (2023)

Genome-Wide Identification of Immune-Related Alternative Splicing and Splicing Regulators Involved in Abdominal Aortic Aneurysm
por: Wu, Shiyong, et al.
Publicado: (2022)

Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients
por: Dai, Zhibing, et al.
Publicado: (2023)

Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning
por: Tian, Yuxi, et al.
Publicado: (2020)

Identification of Key Genes and Pathways Associated With Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis
por: Shen, Zhimin, et al.
Publicado: (2021)

Comprehensive Identification and Alternative Splicing of Microexons in Drosophila
por: Pang, Ting-Lin, et al.
Publicado: (2021)

A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma
por: Wu, Zhipeng, et al.
Publicado: (2020)

Comprehensive Analysis of Splicing Factor and Alternative Splicing Event to Construct Subtype-Specific Prognosis-Predicting Models for Breast Cancer
por: Zhang, He, et al.
Publicado: (2021)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
por: Huan, Sheng, et al.
Publicado: (2022)

7SK Acts as an Anti-tumor Factor in Tongue Squamous Cell Carcinoma
por: Zhang, Bowen, et al.
Publicado: (2021)

A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma
por: Guo, Wenna, et al.
Publicado: (2017)

Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Identification of Deep-Intronic Splice Mutations in a Large Cohort of Patients With Inherited Retinal Diseases
por: Qian, Xinye, et al.
Publicado: (2021)

Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma
por: Bai, Yuping, et al.
Publicado: (2021)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022)

Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing
por: Deng, Jiaying, et al.
Publicado: (2019)

Identification of a Cancer Stem Cells Signature of Head and Neck Squamous Cell Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2022)

Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Liu, Xingyu, et al.
Publicado: (2020)

Genome-wide identification of alternative splicing associated with histone deacetylase inhibitor in cutaneous T-cell lymphomas
por: Yu, Shirong, et al.
Publicado: (2022)

Differential Expression and Alternative Splicing of Transcripts Associated With Cisplatin-Induced Chemoresistance in Nasopharyngeal Carcinoma
por: Zhang, Jian, et al.
Publicado: (2020)

Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
por: Fu, Denggang, et al.
Publicado: (2020)

Combining Pathway Identification and Breast Cancer Survival Prediction via Screening-Network Methods
por: Iuliano, Antonella, et al.
Publicado: (2018)

Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022)

Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck
por: Li, Chunyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c7lc79en7l7fsec8o6occ9thtq